Stock AnalizGenpact LTD G
Professional Services · IPO 2007 · data as of November 13, 2026
Genpact LTD (G) is a consumer discretionary company listed in the US with a market value of about $7.3B. In the twelve months to September 30, 2026 it had revenue of $5.3B and net income of $588M, a net margin of 11.0%.
Its overall Stock Analiz score is 3.4 out of 5 (good). The strongest part is shareholder returns (5/5); the weakest is future growth (1/5).
Key numbers: a P/E of 12.7, a price to free cash flow of 20.5, 5-year revenue growth of 6% a year, a 5-year average ROIC of 12%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 30% above the current price.
Score: 3.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Checks not passed
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.1B | $4.8B | $4.5B | $4.4B | $4.0B | $3.7B | $3.5B | $3.0B | $2.7B | $2.6B |
| Net income | $588M | $552M | $514M | $631M | $353M | $369M | $308M | $305M | $282M | $263M | $270M |
| Free cash flow | $357M | $735M | $533M | $435M | $393M | $641M | $514M | $353M | $255M | $302M | $264M |
| EPS (diluted) | $3.43 | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 | $1.57 | $1.56 | $1.45 | $1.34 | $1.28 |
| Net margin | 11.0% | 10.9% | 10.8% | 14.1% | 8.1% | 9.2% | 8.3% | 8.7% | 9.4% | 9.6% | 10.5% |
| ROIC | — | 13.2% | 14.0% | 13.4% | 11.4% | 10.1% | 9.6% | 9.6% | 11.2% | 10.9% | 13.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 11 analysts is $47.64, 9% above the current price; targets range from $41.00 to $58.00; the consensus rating is “Buy”; expected EPS is $4.14 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Genpact LTD’s P/E ratio?
About 12.7, based on the last twelve months of diluted earnings per share (forward P/E about 9.9).
Is Genpact LTD stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 30% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Genpact LTD pay a dividend?
Yes. The dividend yield is about 1.72%, and it has paid dividends for 9 years in our data.
Is Genpact LTD a good stock to buy?
We do not give buy or sell advice. Genpact LTD scores 3.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.